Observational Study of Small Pancreatic Neuroendocrine Incidentalomas: A Tertiary Referral Center Experience Abstract #1710

Introduction: Incidence in small pancreatic neuroendocrine incidentalomas (PNETs-I) are increasing and its management remains controversial
Aim(s): A descriptive analysis of all patients and a comparative study between observation group(OG) vs resection group(RG) was made
Materials and methods: Since March 2000, 46 patients with non functioning PNETs-I≤30mm were evaluated in our center
Conference: 14th Annual ENETS conference (2017)
Category: Epidemiology/Natural history/Prognosis - Descriptive epidemiology
Presenting Author: Inmaculada Peiró Martínez
Keywords: PNETs

To read results and conclusion, please login ...

Further abstracts you may be interested in

#1023 Streptozotocin/5-Fluorouracil (STZ/5FU) Chemotherapy in G1-G2 Pancreatic Neuroendocrine Tumors (pNETs): Single Institution Experience
Introduction: STZ is the only FDA-approved antiblastic drug for well-/moderately-differentiated NETs. To date, no clear therapeutic sequence is defined for medical treatment of advanced pNETs.
Conference: 11th Annual ENETS Conference (2014)
Category: Medical treatment - Chemotherapy
Presenting Author: Sara Cingarlini
#2243 Somatostatin Analogs (SSAs) as Effective Treatment of Resectable, non Metastatic, non Functioning Pancreatic Neuroendocrine Tumors (NF-pNETs) in Patients Unfit for Surgery. A Case Series.
Introduction: SSAs are used to treat symptomatic functioning pNETs and to prolong progression free survival in metastatic, G1/G2, somatostatin receptor-positive pNETs. Pancreatic surgery is burdened with important morbidity and mortality, especially in patients with increased anaesthesiological risk.
Conference: 15th Annual ENETS conference (2018)
Category: Case reports
Presenting Author: Chiara Nessi
Authors: Nessi C, Paiella S, Miotto M, Viviani E, ...
#808 Characteristics and Determinants of Long-Term Outcome for Resectable Sporadic Non-Functional Pancreatic Neuroendocrine Tumors (NF-PNETs): Updated 16-year Experience from Two Large Chinese Centers
Introduction: Non-functional pancreatic neuroendocrine tumors (NF-PNETs) are increasingly recognized with unique biology.
Conference: 11th Annual ENETS Conference (2014)
Category: Surgical treatment
Presenting Author: M.D. Xu Han
Authors: Jin G, Han X, Jin D, Hu X, ...
Keywords: NF-PNETs
#1702 Comparative Retrospective Analysis of pNETs Treatment with Everolimus (E) and Sunitinib (S).
Introduction: Two targeted compounds are validated for treatment of pNETs – E and S.
Conference: 14th Annual ENETS conference (2017)
Category: Medical treatment - Targeted therapies
Presenting Author: Vera Gorbunova
#2064 The Difficulties in Managing Metastatic Pancreatic Neuroendocrine Tumours (pNETs) Causing Cushing’s Syndrome (CS)
Introduction: The pNETs causing CS are very rare and aggressive. Despite the use of various therapeutic modalities, their management is not well-established, representing nowadays a challenge.
Conference: 15th Annual ENETS conference (2018)
Category: Case reports
Presenting Author: Inmaculada Peiró Martínez